Evaluation of Heterogeneity of DNA Ploidy in Early Gastric Cancers

por Osterheld, M. C., Laurini, R., Saraga, E., Bosman, F. T.
Publicado 1999

Prognostic significance of CEA immunoreactivity patterns in large bowel carcinoma tissue.

por Wiggers, T., Arends, J. W., Verstijnen, C., Moerkerk, P. M., Bosman, F. T.
Publicado 1986

A comparative evaluation of various invasion assays testing colon carcinoma cell lines

por Both, N J de, Vermey, M, Dinjens, W N, Bosman, F T
Publicado 1999

DNA-Ploidy in Advanced Gastric Carcinoma is Less Heterogeneous than in Early Gastric Cancer

por Osterheld, Maria‐Chiara, Caron, Liette, Demierre, Mireille, Laurini, Ricardo, Bosman, F. T.
Publicado 2004

Evaluation of DNA-Ploidy Heterogeneity in Gastric Cancers

por Osterheld, M. C., Laurini, R. N., Saraga, E. P., Bosman, F. T.
Publicado 2008

Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene

por Renaud, S., Loukinov, D., Abdullaev, Z., Guilleret, I., Bosman, F. T., Lobanenkov, V., Benhattar, J.
Publicado 2007

The prognostic value of morphometrical features and cellular DNA content in cis-platin treated late ovarian cancer patients.

por Baak, J. P., Schipper, N. W., Wisse-Brekelmans, E. C., Ceelen, T., Bosman, F. T., van Geuns, H., Wils, J.
Publicado 1988

In vivo and in vitro invasion in relation to phenotypic characteristics of human colorectal carcinoma cells.

por de Vries, J. E., Dinjens, W. N., De Bruyne, G. K., Verspaget, H. W., van der Linden, E. P., de Bruïne, A. P., Mareel, M. M., Bosman, F. T., ten Kate, J.
Publicado 1995

Glutathione S-transferase M1-null genotype as risk factor for SOS in oxaliplatin-treated patients with metastatic colorectal cancer

por Vreuls, C P H, Olde Damink, S W M, Koek, G H, Winstanley, A, Wisse, E, Cloots, R H E, van den Broek, M A J, Dejong, C H C, Bosman, F T, Driessen, A
Publicado 2013